-
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. DC CAFC
- 1:04-cv-03521
- D. Md.
- Judge: Richard D. Bennett
- Filed: 11/02/2004
- Closed: 10/01/2018
- Latest Docket Entry: 09/26/2018
- PACER
1
Plaintiff
3
Defendants
1
Accused
Product
2
Patents-in-Suit
5,082
Days in
Litigation
-
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. DC CAFC
- 1:04-cv-03521
- D. Md.
- Judge: Richard D. Bennett
- Filed: 11/02/2004
- Closed: 10/01/2018
- Latest Docket Entry: 09/26/2018
- PACER
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Elan Corporation PLC
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Metaxalone | US 6,219,674 B1 | All Asserted Claims |
No infringement
Entry 167
|
| MetaxaloneMuscle relaxant skelaxin | US 6,584,472 B2 | All Asserted Claims |
No infringement
Entry 226Entry 167 |
Elan Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| MetaxaloneMuscle relaxant skelaxin | US 6,219,674 B1 | All Asserted Claims |
No infringement
Entry 226Entry 167 Entry 254 |
| MetaxaloneMuscle relaxant skelaxin | US 6,584,472 B2 | All Asserted Claims |
No infringement
Entry 167Entry 254 |
King Pharmaceuticals Incorporated
- 2 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| MetaxaloneMuscle relaxant skelaxin | US 6,219,674 B1 | All Asserted Claims |
No infringement
Entry 226Entry 167 |
| MetaxaloneMuscle relaxant skelaxin | US 6,584,472 B2 | All Asserted Claims |
No infringement
Entry 226Entry 167 |
